Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older

Am J Med. 1995 May;98(5):464-8. doi: 10.1016/S0002-9343(99)80346-5.

Abstract

Objective: To perform a cost-benefit analysis of screening for hereditary hemochromatosis.

Patients and methods: A total of 3,977 consecutive men > or = 30 years of age who presented for routine health checkups at a health maintenance organization medical center were screened for hereditary hemochromatosis by measuring transferrin saturation. Subjects with repeated transferrin saturation > or = 62% and ferritin level > or = 500 ng/mL (> or = 500 micrograms/L) were referred for liver biopsy. Subjects with transferrin saturation < 15% were referred for evaluation. Laboratory testing, screening, and abnormal screening test evaluation procedures were identified by chart review.

Results: Forty patients had transferrin saturation > or = 62%. One hundred seventy-two had transferrin saturation < 15%. Eight patients with hemochromatosis were identified. The 3 patients most seriously affected had hepatic iron concentrations > 250 mumol/g dry weight. Two of them had hepatic fibrosis. Seven cases of hemochromatosis were found among 1,974 white subjects who were screened. Only 1 case was found among the remaining subjects.

Conclusions: Our observations support routine screening with transferrin saturation for white men > or = 30 years of age.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Ambulatory Care
  • Cost-Benefit Analysis
  • Ferritins / metabolism
  • Hemochromatosis / economics*
  • Hemochromatosis / ethnology
  • Hemochromatosis / genetics
  • Hemochromatosis / metabolism
  • Hemochromatosis / prevention & control*
  • Humans
  • Liver / metabolism
  • Male
  • Mass Screening / economics*
  • Mass Screening / methods
  • Middle Aged
  • Surveys and Questionnaires
  • Transferrin / metabolism

Substances

  • Transferrin
  • Ferritins